• Goodarz Danaei


Lim, Carl-Emil, Björn Pasternak, Björn Eliasson, Goodarz Danaei and Peter Ueda. 2023. Use of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists according to the 2019 ESC guidelines and the 2019 ADA/EASD consensus report in a national population of patients with type 2 diabetes. European Journal of Preventive Cardiology 30, no. 8 (June): 634-643.